Kv 11.1 (hERG)-induced cardiotoxicity: a molecular insight from a binding kinetics study of prototypical Kv 11.1 (hERG) inhibitors.
about
Application of a systems pharmacology model for translational prediction of hERG-mediated QTc prolongation.Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?Pharmacokinetic-pharmacodynamic modelling of drug-induced QTc interval prolongation in man: prediction from in vitro human ether-à-go-go-related gene binding and functional inhibition assays and conscious dog studies.A binding kinetics study of human adenosine A3 receptor agonists.A two-state model for the kinetics of competitive radioligand binding.
P2860
Kv 11.1 (hERG)-induced cardiotoxicity: a molecular insight from a binding kinetics study of prototypical Kv 11.1 (hERG) inhibitors.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Kv 11.1 (hERG)-induced cardiot ...... cal Kv 11.1 (hERG) inhibitors.
@en
Kv 11.1
@nl
type
label
Kv 11.1 (hERG)-induced cardiot ...... cal Kv 11.1 (hERG) inhibitors.
@en
Kv 11.1
@nl
prefLabel
Kv 11.1 (hERG)-induced cardiot ...... cal Kv 11.1 (hERG) inhibitors.
@en
Kv 11.1
@nl
P2860
P356
P1476
Kv 11.1 (hERG)-induced cardiot ...... ical Kv 11.1 (hERG) inhibitors
@en
P2093
P2860
P304
P356
10.1111/BPH.12967
P407
P577
2014-12-15T00:00:00Z